ARCHIVES

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

Colorado Institutions Vying to Build First Carbon Ion Center in the U.S.

September 26, 2014

House Appropriators Approve NIH Increase; Clinton Threatens Veto Over Education Cuts

July 17, 1998

Chabner Cautions Against Downsizing, Consolidation Of NCI Intramural Programs

March 3, 1995

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000

AACR Grant Programs. NIH RFA Available.

June 29, 2001

Conversation with The Cancer Letter: Rosen’s New Role Is Part Of An Evolution Of Administrative Structure at City of Hope

November 1, 2013